GlobalData on MSN11 小时
Lunit’s SCOPE AI tools demonstrate value in HER2 biomarker evaluation
Lunit’s SCOPE HER2 AI model demonstrated an 86.7% accuracy compared to pathologist assessments for HER2 immunohistochemistry (IHC).